CNS Response ranked #21 Holder of Pervasive Neurotech Intellectual Property*

.

CNS Response is a cloud-based out­comes-shar­ing plat­form for EEG data. The pur­pose of the plat­form, named PEER (Psy­chi­atric EEG Eval­u­a­tion Reg­istry) is to improve treat­ment deci­sions for psy­chi­atric con­di­tions by ref­er­enc­ing the thou­sands of out­comes from pre­vi­ous tri­al instances.The more clin­i­cians exchange EEG out­comes with each oth­er, the less treat­ment deci­sions will be based on tri­al and error.

• Loca­tion: Aliso Viejo, CA
• Stock Tick­er: OTCMKTS:CNSO
• Num­ber of employ­ees: <100
• Per­va­sive neu­rotech US patent grants: 9
• Per­va­sive neu­rotech US pend­ing appli­ca­tions: 2

*CNS Response ranked #21 in Sharp­Brains’ Per­va­sive Neu­rotech IP Strength Index, thanks to patents such as:

• US6622036: Method for clas­si­fy­ing and treat­ing phys­i­o­log­ic brain imbal­ances using quan­ti­ta­tive EEG
• US7177675: Elec­troen­cephalog­ra­phy based sys­tems and meth­ods for select­ing ther­a­pies and pre­dict­ing outcomes
• US7754190: Method for deter­min­ing drug effects using quan­ti­ta­tive EEG
• US8239013: EEG pre­dic­tion method for med­ica­tion response

To learn more about Sharp­Brains’ take on the orga­ni­za­tion’s #Per­va­siveNeu­rotech IP port­fo­lio, and over­all data and trends, click on Per­va­sive Neu­rotech­nol­o­gy: A Ground­break­ing Analy­sis of 10,000+ Patent Fil­ings Trans­form­ing Med­i­cine, Health, Enter­tain­ment, and Busi­ness.